Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 201

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy

Open access
Ye, Lupeng, Park, Jonathan J., Peng, Lei, Yang, Quanjun, Chow, Ryan D., Dong, Matthew B., Lam, Stanley Z., Guo, Jianjian, Tang, Erting, Zhang, Yueqi, Wang, Guangchuan, Dai, Xiaoyun, Du, Yaying, Kim, Hyunu R., Cao, Hanbing, Errami, Youssef, Clark, Paul, Bersenev, Alexey, Montgomery, Ruth R., Chen, Sidi · 2022 · Cell Metabolism

Abstract

Chimeric antigen receptor (CAR)-T cell-based immunotherapy for cancer and immunological diseases has made great strides, but it still faces multiple hurdles. Finding the right molecular targets to engineer T cells toward a desired function has broad implications for the armamentarium of T cell-centered therapies. Here, we developed a dead-guide RNA (dgRNA)-based CRISPR activation screen in primary CD8+ T cells, and identified gain-of-function (GOF) targets for CAR-T engineering. Targeted knock-in or overexpression of a lead target, PRODH2, enhanced CAR-T-based killing and in vivo efficacy in multiple cancer models. Transcriptomics and metabolomics in CAR-T cells revealed that augmenting PRODH2 expression reshaped broad and distinct gene expression and metabolic programs. Mitochondrial, metabolic and immunological analyses showed that PRODH2 engineering enhances the metabolic and immune functions of CAR-T cells against cancer. Together these findings provide a system for identification of GOF immune boosters, and demonstrate PRODH2 as a target to enhance CAR-T efficacy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2022.02.009

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Cited by

See all 201

Metadata

Authors
Ye, L., Park, J. J., Peng, L., Yang, Q., Chow, R. D., Dong, M. B., Lam, S. Z., Guo, J., Tang, E., Zhang, Y., Wang, G., Dai, X., Du, Y., Kim, H. R., Cao, H., Errami, Y., Clark, P., Bersenev, A., Montgomery, R. R., & Chen, S.
Venue
Cell Metabolism
Publisher
Elsevier BV
Published
2022-04
Volume
34
Issue
4
Pages
595-614.e14
ISSN
1550-4131 (ISSN-L)
OpenAlex
W4221014433
Cited by
201
References
32
FWCI
15.41
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy. https://app.cochat.ai/papers/10.1016/j.cmet.2022.02.009
The paper
Ye, L., Park, J. J., Peng, L., Yang, Q., Chow, R. D., Dong, M. B., Lam, S. Z., Guo, J., Tang, E., Zhang, Y., Wang, G., Dai, X., Du, Y., Kim, H. R., Cao, H., Errami, Y., Clark, P., Bersenev, A., Montgomery, R. R., & Chen, S. (2022). A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy. Cell Metabolism. https://doi.org/10.1016/j.cmet.2022.02.009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.